Salix Reports Positive Trial Results
Salix Pharmaceuticals Ltd. (SLXP) reported positive trial results for two drugs to treat colitis and irritable bowel syndrome sending the stock price up $1.64 to $12.96.
posted by FC Market News at 2:23 PM
0 Comments:
Post a Comment
<< Home